Spectrum Brands Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Spectrum Brands Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Sep 30, 2019 | $993.00M | Nov 15, 2019 |
| FY2019 | Jun 30, 2019 | $1.02B | Nov 15, 2019 |
| FY2019 | Mar 31, 2019 | $906.70M | Nov 15, 2019 |
| FY2019 | Dec 30, 2018 | $880.30M | Nov 15, 2019 |
| FY2019 | Sep 30, 2018 | $974.40M | Nov 15, 2019 |
| FY2019 | Jun 30, 2018 | $1.03B | Nov 15, 2019 |
| FY2019 | Mar 31, 2018 | $882.60M | Nov 15, 2019 |
| FY2019 | Dec 31, 2017 | $922.30M | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | $787.80M | Nov 23, 2018 |
| FY2018 | Jun 30, 2017 | $863.00M | Nov 23, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.81B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $2.96B | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $2.92B | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $3.13B | Nov 15, 2024 |
| FY2021 | Sep 30, 2021 | $757.80M | Nov 23, 2021 |
| FY2021 | Jul 4, 2021 | $743.80M | Nov 23, 2021 |
| FY2021 | Apr 4, 2021 | $760.30M | Nov 23, 2021 |
| FY2021 | Jan 3, 2021 | $736.20M | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | $1.17B | Nov 18, 2020 |
| FY2020 | Jun 30, 2020 | $984.30M | Nov 18, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $1.32B | Nov 20, 2017 |
| FY2017 | Jun 30, 2017 | $1.30B | Nov 20, 2017 |
| FY2017 | Mar 31, 2017 | $1.17B | Nov 20, 2017 |
| FY2017 | Dec 31, 2016 | $1.21B | Nov 20, 2017 |
| FY2017 | Sep 30, 2016 | $1.25B | Nov 20, 2017 |
| FY2017 | Jun 30, 2016 | $1.36B | Nov 20, 2017 |
| FY2017 | Mar 31, 2016 | $1.21B | Nov 20, 2017 |
| FY2017 | Dec 31, 2015 | $1.22B | Nov 20, 2017 |
| FY2016 | Sep 30, 2015 | $1.28B | Nov 23, 2016 |
| FY2016 | Jun 30, 2015 | $1.20B | Nov 23, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.03B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.11B | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $924.30M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $990.40M | Nov 15, 2024 |
| FY2021 | Sep 30, 2021 | $258.20M | Nov 23, 2021 |
| FY2021 | Jul 4, 2021 | $262.60M | Nov 23, 2021 |
| FY2021 | Apr 4, 2021 | $261.00M | Nov 23, 2021 |
| FY2021 | Jan 3, 2021 | $252.80M | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | $423.00M | Nov 18, 2020 |
| FY2020 | Jun 30, 2020 | $348.90M | Nov 18, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $99.90M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $124.80M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $1.80B | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $71.60M | Nov 15, 2024 |
| FY2021 | Sep 30, 2021 | $50.20M | Nov 23, 2021 |
| FY2021 | Jul 4, 2021 | $30.70M | Nov 23, 2021 |
| FY2021 | Apr 4, 2021 | $36.70M | Nov 23, 2021 |
| FY2021 | Jan 3, 2021 | $72.10M | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | $45.40M | Nov 18, 2020 |
| FY2020 | Jun 30, 2020 | $145.10M | Nov 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $124.90M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $170.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | ($205.60M) | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $23.20M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $97.10M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $8.60M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | ($152.40M) | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $224.20M | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $287.50M | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $334.90M | Nov 23, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $23.20M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $28.10M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $22.50M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $26.70M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $29.80M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $29.20M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $32.10M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $44.60M | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $44.60M | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $27.00M | Nov 23, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $882.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $953.40M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $888.80M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $995.70M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $46.90M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $52.40M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $22.00M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $36.30M | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $39.30M | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $31.90M | Nov 23, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $203.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $162.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | ($409.70M) | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | ($53.80M) | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $288.40M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $290.30M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $1.10M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $343.30M | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $840.20M | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $913.30M | Nov 23, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $38.30M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $44.00M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $59.00M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $64.00M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $43.60M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $44.10M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $40.40M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $75.90M | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $81.80M | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $61.00M | Nov 23, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.38B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $3.84B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $5.26B | Nov 15, 2024 |
| FY2023 | Sep 30, 2022 | $5.78B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $5.34B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $5.11B | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $5.25B | Nov 18, 2020 |
| FY2019 | Sep 30, 2018 | $7.80B | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | $35.85B | Nov 23, 2018 |
| FY2017 | Sep 30, 2016 | $33.58B | Nov 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.47B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.70B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $2.74B | Nov 15, 2024 |
| FY2023 | Sep 30, 2022 | $4.51B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $3.86B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $3.69B | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $3.52B | Nov 18, 2020 |
| FY2019 | Sep 30, 2018 | $6.21B | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | $33.90B | Nov 23, 2018 |
| FY2017 | Sep 30, 2016 | $31.76B | Nov 20, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.91B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $2.14B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $2.52B | Nov 15, 2024 |
| FY2023 | Sep 30, 2022 | $1.26B | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $1.47B | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $1.41B | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $1.72B | Nov 18, 2020 |
| FY2019 | Sep 30, 2018 | $1.58B | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | $758.00M | Nov 23, 2018 |
| FY2017 | Sep 30, 2016 | $638.10M | Nov 20, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $866.80M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $864.90M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $854.70M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $953.10M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $867.20M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $627.20M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $626.00M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $1.45B | Nov 18, 2020 |
| FY2019 | Sep 30, 2017 | $1.46B | Nov 15, 2019 |
| FY2018 | Sep 30, 2016 | $2.13B | Nov 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.22B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $2.17B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $2.10B | Nov 15, 2024 |
| FY2023 | Sep 30, 2022 | $362.10M | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $359.90M | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $243.90M | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $223.80M | Nov 18, 2020 |
| FY2019 | Sep 30, 2018 | ($180.10M) | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | ($925.90M) | Nov 23, 2018 |
| FY2017 | Sep 30, 2016 | ($1.03B) | Nov 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $123.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $368.90M | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $753.90M | Nov 15, 2024 |
| FY2023 | Sep 30, 2022 | $243.70M | Nov 21, 2023 |
| FY2022 | Sep 30, 2021 | $187.90M | Nov 22, 2022 |
| FY2021 | Sep 30, 2020 | $531.60M | Nov 23, 2021 |
| FY2020 | Sep 30, 2019 | $627.10M | Nov 18, 2020 |
| FY2019 | Sep 30, 2018 | $552.50M | Nov 15, 2019 |
| FY2018 | Sep 30, 2017 | $270.10M | Nov 23, 2018 |
| FY2018 | Sep 30, 2016 | $465.20M | Nov 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $496.10M | Nov 18, 2025 |
| FY2024 | Sep 30, 2024 | $496.10M | Nov 15, 2024 |
| FY2023 | Sep 30, 2023 | $1.49B | Nov 21, 2023 |
| FY2022 | Sep 30, 2022 | $3.10B | Nov 22, 2022 |
| FY2021 | Sep 30, 2021 | $2.44B | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | $2.35B | Nov 18, 2020 |
| FY2019 | Sep 30, 2019 | $2.38B | Nov 15, 2019 |
| FY2017 | Sep 30, 2017 | $5.87B | Nov 20, 2017 |
| FY2017 | Sep 30, 2016 | $5.64B | Nov 20, 2017 |
| FY2016 | Sep 30, 2015 | $6.11B | Nov 23, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 3 | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | 4 | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | 45 | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | 1 | Nov 15, 2024 |
| FY2021 | Sep 30, 2021 | 1 | Nov 23, 2021 |
| FY2021 | Jul 4, 2021 | 0 | Nov 23, 2021 |
| FY2021 | Apr 4, 2021 | 0 | Nov 23, 2021 |
| FY2021 | Jan 3, 2021 | 1 | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Nov 18, 2020 |
| FY2020 | Jun 30, 2020 | 3 | Nov 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 3 | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | 4 | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | 45 | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | 1 | Nov 15, 2024 |
| FY2021 | Sep 30, 2021 | 1 | Nov 23, 2021 |
| FY2021 | Jul 4, 2021 | 0 | Nov 23, 2021 |
| FY2021 | Apr 4, 2021 | 0 | Nov 23, 2021 |
| FY2021 | Jan 3, 2021 | 1 | Nov 23, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Nov 18, 2020 |
| FY2020 | Jun 30, 2020 | 3 | Nov 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | 53.40M | Nov 23, 2018 |
| FY2018 | Sep 30, 2017 | 200.60M | Nov 23, 2018 |
| FY2017 | Sep 30, 2016 | 200.79M | Nov 20, 2017 |
| FY2017 | Sep 30, 2015 | 201.38M | Nov 20, 2017 |
| FY2015 | Sep 30, 2014 | 201.38M | Nov 20, 2015 |
| FY2013 | Sep 30, 2013 | 142.38M | Nov 27, 2013 |
| FY2015 | Sep 30, 2012 | 202.30M | Nov 20, 2015 |
| FY2012 | Sep 30, 2011 | 139.35M | Nov 27, 2012 |
| FY2011 | Sep 30, 2010 | 139,197 | Dec 14, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $48.20M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $50.60M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $66.50M | Nov 18, 2025 |
| FY2024 | Sep 30, 2022 | $68.60M | Nov 15, 2024 |
| FY2023 | Sep 30, 2021 | $71.50M | Nov 21, 2023 |
| FY2022 | Sep 30, 2020 | $75.20M | Nov 22, 2022 |
| FY2021 | Sep 30, 2019 | $85.50M | Nov 23, 2021 |
| FY2020 | Sep 30, 2018 | $22.40M | Nov 18, 2020 |